Rigel Pharmaceuticals Inc. (United States) is listed on the Nasdaq and has a market capitalization of $794.01 million, with shareholders equity totaling $425.42 million.
The company employs approximately 169 people and operates in the Services sector, within the Commercial Services industry.
Over the past 12 months, Rigel Pharmaceuticals Inc. reported $276.78 million in revenue, generating net income of $321.90 million.
Key financial metrics include a P/E ratio of 2.47, a price-to-book (P/B) ratio of 1.87, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker RIGL.